GSK
GSK
GSK
880 hedge funds and large institutions have $16.7B invested in GSK in 2025 Q3 according to their latest regulatory filings, with 98 funds opening new positions, 317 increasing their positions, 305 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more repeat investments, than reductions
Existing positions increased: 317 | Existing positions reduced: 305
0.51% more ownership
Funds ownership: 18.45% → 18.96% (+0.51%)
0% more funds holding
Funds holding: 880 → 880 (0)
Holders
880
Holding in Top 10
13
Calls
$267M
Puts
$130M
Top Buyers
| 1 | +$222M | |
| 2 | +$84.8M | |
| 3 | +$72M | |
| 4 |
Holocene Advisors
New York
|
+$64.3M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$58.9M |
Top Sellers
| 1 | -$121M | |
| 2 | -$84.6M | |
| 3 | -$68.3M | |
| 4 |
AOI
Auto-Owners Insurance
Lansing,
Michigan
|
-$35.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$25.6M |